FREE WEBINAR

GLP-1 & Peptide Therapies Wellness Webinar

Watch On Demand

Learn your options for medical weight loss and metabolic health, including GLP-1 medications and peptide therapies, and what to expect if you’re considering them

Featured Guest Panelist: Dr. Jessica Chung, DNP, FNP-C

Doctorally prepared board-certified nurse practitioner with 16 years in healthcare and 11 years in primary care and internal medicine. Founder of J.C. Healthcare & Associates.

FREE WEBINAR

GLP-1 & Peptide Therapies Wellness Webinar

Watch On Demand

Learn your options for medical weight loss and metabolic health, including GLP-1 medications and peptide therapies, and what to expect if you’re considering them

Featured Guest Speaker: Dr. Jessica Chung, DNP, FNP-C

Doctorally prepared board-certified nurse practitioner with 16 years in healthcare and 11 years in primary care and internal medicine. Founder of J.C. Healthcare & Associates.

What You'll Learn:

  • Why GLP-1 medications have gained so much attention for weight management and metabolic health.

  • What peptides are and the different roles they play in the body

  • How peptides are being explored for energy, recovery, and longevity.

  • Important things to understand if you are considering GLP-1 for peptide therapies.

  • How safely access quality GLP-1s and peptide therapies.

FEATURED GUEST SPEAKER

Dr. Jessica Chung,

DNP, FNP-C

Founder, J.C. Healthcare & Associates

Dr. Chung is a Doctorally Prepared Board-Certified Nurse Practitioner with over 16 years in healthcare and 11 years practicing in primary care and internal medicine. She is the founder of J.C. Healthcare & Associates, based in Tampa, Florida.

Dr. Chung will share clinical insights on GLP-1 medications and metabolic health, along with her personal experience and progress observed in a few patients. Additional guest speakers will present educational information on other peptides.

Current progress: Lost 40 lbs on GLP-1 therapy

Watch On Demand

Disclaimer

This webinar is for educational purposes only.

Eligibility for GLP-1 or peptide therapies is determined by licensed healthcare providers through the telehealth platform.